Actions of bretylium tosylate on the cardiovascular system of the dog.
D000818:Animals; D001013:Aorta, Thoracic / Q000187:drug effects; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects*; D001949:Bretylium Compounds / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D003331:Coronary Vessels / Q000187:drug effects; D004285:Dogs; D005934:Glucagon / Q000494:pharmacology; D006321:Heart / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007545:Isoproterenol / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D014655:Vascular Resistance / Q000187:drug effects
D001949:Bretylium Compounds; D001285:Atropine; D012110:Reserpine; D005934:Glucagon; D011433:Propranolol; D007545:Isoproterenol; D010646:Phentolamine